Rhopressa and Roclatan

In the pipeline: What’s new and what’s coming in optometry technologyKeeping patients informed on the latest procedures and equipment available to treat their disorders is half the battle, says Paul Karpecki, OD, FAAO, at American Optometric Association’s Optometry’s Meeting.
A bullish view: Navigating beyond glaucoma company mistakesCompanies specializing in glaucoma products can make billions of dollars, but only if they can find a path through a minefield of scientific, regulatory, and marketing hazards, according to Richard A. Lewis, MD.